导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.03% | 255/338 |
| 近一周 | -3.24% | 215/344 |
| 近一月 | -6.82% | 260/344 |
| 近一季 | -10.30% | 307/344 |
| 近半年 | -5.71% | 232/340 |
| 近一年 | -15.25% | 208/333 |
| 近两年 | 1.55% | 277/298 |
| 近三年 | -4.41% | 217/236 |
| 成立以来 | 64.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-14.28% 282/360 |
3.24% 171/366 |
- - |
- - |
| 2025 | 11.68% 268/358 |
-6.06% 235/340 |
10.78% 125/348 |
6.82% 250/354 |
0.46% 161/358 |
| 2024 | 4.42% 216/329 |
7.59% 84/280 |
-7.92% 277/310 |
3.05% 201/318 |
2.29% 125/329 |
| 2023 | 10.36% 85/275 |
16.83% 41/205 |
6.42% 88/230 |
-16.67% 230/262 |
6.51% 133/276 |
| 2022 | -15.16% 69/201 |
-9.77% 94/153 |
-14.63% 115/164 |
2.06% 19/189 |
7.93% 117/202 |
| 2021 | 15.71% 51/150 |
2.81% 111/312 |
7.81% 99/328 |
-6.82% 198/358 |
12.04% 15/151 |
| 2020 | 23.25% 27/103 |
-20.46% 216/280 |
20.77% 94/295 |
10.80% 45/299 |
15.79% 47/305 |
| 2019 | 27.34% 28/88 |
10.76% 109/258 |
5.19% 35/267 |
-0.79% 168/253 |
10.16% 75/266 |
| 2018 | - - |
- - |
- - |
2.82% 106/225 |
-15.33% 172/241 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 易方达标普消费品指数C VS. 建信富时100指数(QDII)人民币A(539003) |